Cargando…

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer

OBJECTIVE: Precision oncology depends on translating molecular data into therapy recommendations. However, with the growing complexity of next-generation sequencing-based tests, clinical interpretation of somatic genomic mutations has evolved into a formidable task. Here, we compared the performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perakis, Samantha O, Weber, Sabrina, Zhou, Qing, Graf, Ricarda, Hojas, Sabine, Riedl, Jakob M, Gerger, Armin, Dandachi, Nadia, Balic, Marija, Hoefler, Gerald, Schuuring, Ed, Groen, Harry J M, Geigl, Jochen B, Heitzer, Ellen, Speicher, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513637/ https://www.ncbi.nlm.nih.gov/pubmed/32967919 http://dx.doi.org/10.1136/esmoopen-2020-000872

Ejemplares similares

Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
por: Zhou, Qing, et al.
Publicado: (2020)

The potential of liquid biopsies for the early detection of cancer
por: Heitzer, Ellen, et al.
Publicado: (2017)

Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
por: Mohan, Sumitra, et al.
Publicado: (2014)

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
por: Belic, Jelena, et al.
Publicado: (2018)

Genetic and epigenetic analysis of putative breast cancer stem cell models
por: Balic, Marija, et al.
Publicado: (2013)

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment
por: Dandachi, Nadia, et al.
Publicado: (2020)

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
por: Ulz, Peter, et al.
Publicado: (2016)

On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer
por: Moser, Tina, et al.
Publicado: (2020)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Single circulating tumor cell sequencing for monitoring
por: Auer, Martina, et al.
Publicado: (2013)

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
por: Riedl, Jakob M., et al.
Publicado: (2021)

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
por: Ulz, Peter, et al.
Publicado: (2019)

Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
por: Ulz, Peter, et al.
Publicado: (2020)

Deciphering the molecular landscape of metastatic lobular breast cancer
por: Dandachi, Nadia, et al.
Publicado: (2022)

Genetic profiling of putative breast cancer stem cells from malignant pleural effusions
por: Tiran, Verena, et al.
Publicado: (2017)

Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X
por: Schulz, Eduard, et al.
Publicado: (2014)

Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
por: Weber, Sabrina, et al.
Publicado: (2020)

Preexisting TP53 mutation in therapy-related acute myeloid leukemia
por: Schulz, Eduard, et al.
Publicado: (2014)

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition
por: Tiran, Verena, et al.
Publicado: (2017)

Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma
por: Heitzer, Ellen, et al.
Publicado: (2013)

Emerging concepts in liquid biopsies
por: Perakis, Samantha, et al.
Publicado: (2017)

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study
por: Unseld, Matthias, et al.
Publicado: (2020)

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
por: Heitzer, Ellen, et al.
Publicado: (2013)

Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment
por: Suppan, Christoph, et al.
Publicado: (2019)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
por: Müller, Marian, et al.
Publicado: (2019)

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
por: Pabst, Gabriel, et al.
Publicado: (2020)

Mapping of balanced chromosome translocation breakpoints to the basepair level from microdissected chromosomes
por: Obenauf, Anna C, et al.
Publicado: (2010)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
por: Heitzer, Ellen, et al.
Publicado: (2013)

Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype
por: Čipak Gašparović, Ana, et al.
Publicado: (2019)

Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression
por: Brcic, Iva, et al.
Publicado: (2023)

Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays
por: Geigl, Jochen B., et al.
Publicado: (2009)

High resolution array-CGH analysis of single cells
por: Fiegler, Heike, et al.
Publicado: (2007)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
por: Suppan, Christoph, et al.
Publicado: (2015)

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
por: Seles, Maximilian, et al.
Publicado: (2016)

Analgesia for Sheep in Commercial Production: Where to Next?
por: Small, Alison, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dqdlog7b4rq03q5568gf485cj1